February 10, 2015 Ultragenyx Announces Positive 36-Week Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7
February 09, 2015 CERENIS THERAPEUTICS announces the appointment of a new Chief Medical Officer and new Board Members
February 06, 2015 Orexo commences patent infringement litigation against Actavis concerning Abstral® in the US